Skip to Content

Dear Customer:

The current international situation is complex and volatile, and uncertain tariff policies may potentially impact our product prices. Given these uncertainties, we value your understanding regarding order-related matters.

If you decide to place an order during this period, we reserve the right to adjust the price based on the evolving situation. We understand that market changes may cause inconvenience. We will negotiate with you if there’s a significant price fluctuation due to tariff policy changes before the order’s actual delivery, and in such cases we may adjust or cancel the order as necessary.

For important updates on recent policy changes, please click here for more details.

Merck
CN
  • LncRNA CamK-A Regulates Ca2+-Signaling-Mediated Tumor Microenvironment Remodeling.

LncRNA CamK-A Regulates Ca2+-Signaling-Mediated Tumor Microenvironment Remodeling.

Molecular cell (2018-09-18)
Ling-Jie Sang, Huai-Qiang Ju, Guang-Ping Liu, Tian Tian, Guo-Lin Ma, Yun-Xin Lu, Ze-Xian Liu, Ruo-Lang Pan, Rui-Hua Li, Hai-Long Piao, Jeffrey R Marks, Luo-Jia Yang, Qingfeng Yan, Wenqi Wang, Jianzhong Shao, Yubin Zhou, Tianhua Zhou, Aifu Lin
ABSTRACT

Cancer cells entail metabolic adaptation and microenvironmental remodeling to survive and progress. Both calcium (Ca2+) flux and Ca2+-dependent signaling play a crucial role in this process, although the underlying mechanism has yet to be elucidated. Through RNA screening, we identified one long noncoding RNA (lncRNA) named CamK-A (lncRNA for calcium-dependent kinase activation) in tumorigenesis. CamK-A is highly expressed in multiple human cancers and involved in cancer microenvironment remodeling via activation of Ca2+-triggered signaling. Mechanistically, CamK-A activates Ca2+/calmodulin-dependent kinase PNCK, which in turn phosphorylates IκBα and triggers calcium-dependent nuclear factor κB (NF-κB) activation. This regulation results in the tumor microenvironment remodeling, including macrophage recruitment, angiogenesis, and tumor progression. Notably, our human-patient-derived xenograft (PDX) model studies demonstrate that targeting CamK-A robustly impaired cancer development. Clinically, CamK-A expression coordinates with the activation of CaMK-NF-κB axis, and its high expression indicates poor patient survival rate, suggesting its role as a potential biomarker and therapeutic target.

MATERIALS
Product Number
Brand
Product Description

Roche
Biotin RNA Labeling Mix, sufficient for 20 reactions (transcription), pkg of 40 μL, solution
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
200 nmol
Please contact Customer Service for Availability
CN¥3,123.53
250 nmol
Please contact Customer Service for Availability
CN¥4,583.57